Skip to main content
padlock icon - secure page this page is secure

Open Access Concepts and Prototypes for Formulation and Delivery of Biopharmaceuticals and in Tissue Engineering

Download Article:
(PDF 312.7 kb)
Novel technologies in the discovery of new therapeutic or immunogenic moieties in the fields of low molecular weight and biomacromolecular pharmaceuticals have led to an increasing demand for delivery systems capable of protecting, transporting, and selectively depositing those therapeutic agents at their sites of action, with the aim to control their pharmacological profiles, reduce frequencies of administration, limit side effects and toxicity, and, last but not least, foster patient compliance. This applies particularly to biomacromolecules, i.e. peptide, protein, and nucleic acid biopharmaceuticals. Our group's prime interest in this area is to improve efficacy and safety of drug treatment and vaccination, and contribute to patient-friendly administration modes. In particular, we focus on peptide and protein therapeutics, vaccines and gene medicines. In this summary, we will specifically address three areas: (i) our long-term involvement in the biomedical engineering of particulates as vaccine delivery systems, (ii) skeletal tissue engineering applying human mesenchymal stem cells, and (iii) our engagement in research on cell penetrating peptides (CPP) as carriers for drug delivery.

30 References.

No Supplementary Data.
No Article Media
No Metrics


Document Type: Research Article

Publication date: October 1, 2004

More about this publication?
  • International Journal for Chemistry and Official Membership Journal of the Swiss Chemical Society (SCS) and its Divisions

    CHIMIA, a scientific journal for chemistry in the broadest sense, is published 10 times a year and covers the interests of a wide and diverse readership. Contributions from all fields of chemistry and related areas are considered for publication in the form of Review Articles and Notes. A characteristic feature of CHIMIA are the thematic issues, each devoted to an area of great current significance.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Information for Advertisers
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more